INTRODUCTION
Mercuric chloride (MC) is a well known renal toxicant that destroys proximal tubular epithelial cells at high levels of exposure.1,2) Its toxic effects on the immune system were also reported recently.3,4) Immune mediated glomerulonephritis has been reported also in certain strains of rats,5-9) rabbits10) and mice11) exposed repeatedly to low levels of MC. PVG/c rats given MC repeatedly developed antinuclear antibodies, resulting in glomerulonephritis with deposition of immune complex.8,9) Repeated administration of MC to Brown Norway rats produced biphasic glomerulonephritis, linear deposition of antibasement membrane antibody at an early stage, followed by immune complex-type granular deposition in the glomeruli.5,12) Also, MC induced polyclonal activation of B cells and greatly increased serum IgE levels.13-16) MC modified a certain group of T cells which caused polyclonal activation of autoreactive T cells, followed by the nonspecific activation of B cells.17-19) Suppressor T cells developed, and the rats of that strain recovered from the disease.20-22) In mice, MC induced antinucleolar autoantibodies (AnuA) of the IgG type in outbred ICR mice23) and inbred mice with H-2S haplotype MHC.24-26) Genetic studies of both rats and mice indicated that the MHC class II genes were the major genetic factor controlling the response. 16, 24, 27) The present studies were conducted to obtain information about the mechanism 
RESULTS

AnuA induction in various strains
Repeated administration of 1 mg/kg MC induced AnuA in 8 of 10 ICR mice, while none of the inbred mice developed AnuA ( Table 1 ). The AnuA developed in ICR mice was IgG and it brilliantly stained the nucleoli of R615B2 cells (Fig.  1) . The AnuA reacted similarly with nucleoli from cryostat sections of mouse liver and R615B2 cells, so R615B2 cells were used as the substrate in the following experiments. When the substrate was pretreated with RNase A, the intensity of nucleolar staining was reduced dose-dependently down to complete disappearance. Treatment with low concentrations of trypsin eliminated the nucleolar staining, and at concentrations higher than 0.05%, the substrate was detached from the wells. DNase treatment did not change the intensity of staining.
Kinetic study ICR mice were treated with 1.5 mg/kg MC and bled at 1, 2, 3, 4, 5, 6, 8 and 12 weeks after the start of MC treatment. As shown in Table 2 , AnuA appeared after the 2nd week of the experiment, and the positivities and the titers increased time-dependently. Although the MC injection was ended at the 4th week, hightiter AnuA was continued in many mice until the 12th week. The AnuA was IgG class, and no IgM antibody appeared. Sera from control mice which were killed at the 4th, 8th and 12th week of the experiment did not have AnuA. The serum dilution was 1 : 10. ICR mice with or without pretreatment with FCA received 0.5-2.0 mg/kg MC for 4 weeks. The AnuA titers of mice given only MC were dose-dependent though the positivity was similar in all groups (Table 3) . Mice pretreated with FCA showed higher antibody titers than those given only MC, and this difference was greater in mice given the lower doses of MC. When mice were injected with either FCA or FIA and received 0.2 or 0.5 mg/kg MC, the antibody titers were increased similarly in the two treated groups (Table 4) .
Autoantibodies in nude mice
Athymic nude (nu/nu) and euthymic heterozygous (nu/ +) ICR mice with or without FCA pretreatment were injected with 1 mg/kg MC. As shown in Table  5 , the athymic nude mice, whether given FCA or not, did not develop AnuA. The euthymic heterozygous ICR mice developed autoantibodies, but the positivity was lower than in euthymic homozygous ( +/ +) ICR mice treated similarly in Effect of GK1.5 treatment None of the ICR mice treated with GK 1.5 during the MC treatment developed AnuA, but 6 of 9 mice treated with RPMI 1640 as controls produced autoantibodies (Table 6 ).
DISCUSSION
In this study, repeated administration of low doses of MC induced AnuA in outbred ICR mice, but not in the 5 inbred mice BALB/c, CBA/JN, C57BL/6, C 3H/He, and DBA/2. The reactivity of AnuA induced in the ICR mice was diminished by pretreatment of the substrate with RNase and trypsin but not with DNase. The AnuA induced in SJL mice by MC has similar characteristics.25) These results indicated that the nucleolus antigen(s) recognized by these AnuA may be ribonucleoprotein(s). But the antigen underlying this nucleolar reaction pattern is not thoroughly understood. The nucleolus-specific RNA,29,30) the small nuclear U3 ribonucleoproteins,26) fibrillarinm) and ribosomes32) have been demonstrated so far as nucleolar antigens.
To our knowledge, this is the first report on the production of AnuA caused by MC in nude mice or mice treated with a monoclonal antibody against L3T4. We could not induce AnuA in either nude mice or mice receiving anti-L3T4 antibody. This indicates directly that L3T4-positive T cells may play important roles in the production of AnuA caused by MC in mice. The precise mechanism is not known, but the MC toxicity may release nucleolar component(s), or form new antigen(s) crossreactive with nucleolar component(s), followed by stimulation of T helper cells and B cells. Since MC induces blast transformation of lymphocytes33) and polyclonal activation,14,15,19) the stimulation with nucleolar antigen(s) and simultaneous polyclonal activation of both T and B cells, which may be effected additively or synergistically, may result in production of high-titer AnuA.
Pretreatment with Freund's adjuvant, either FCA or FIA, augmented the AnuA titer, and the effect was more prominent in mice given lower doses of MC. Since it was proposed that the adjuvant stimulated the T helper cells to act on B cells either directly or by secreting lymphokines,34) nucleolar or nucleoli-like antigen(s) released by the MC toxicity may be recognized more effectively in mice pretreated with Freund's adjuvant, and the tendency may have been clearer when the mice were given lower doses of MC. This hypothesis may explain the observation that time duration from the start of MC treatment to the appearance of antinuclear autoantibody were shortened by the pretreatment with FCA in PVG/c rats.8)
In the kinetic study, the antinucleolar autoantibody of the IgG isotype ap- In our experiment, high-titer AnuA could be observed even 8 weeks after the final MC treatment. There have been reported that the MC induced AnuA persisted as long as 6 months in ICR mice") and that the titers continued to increase when SJL and B10.S mice were treated with MC for 12 weeks25,26). These results indicated that the activation of T suppressor cells may not be likely to occur in the mouse system, while T suppressor cells were activated after the 3rd week of MC treatment in the rat system even when the treatment continued20-22).
In conclusion, repeated administration of low doses of MC to susceptible mice may release nucleolar antigen(s) or form new antigen(s) crossreactive with nucleolar component because of the toxicity. AnuA may be produced by autoreactive B cells in cooperation with L3T4-positive T cells. 
